TEVA PHARMACEUTICAL INDUSTRIES LIMITED Property, Plant and Equipment, Gross
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) had Property, Plant and Equipment, Gross of $8.81 billion as of 2025-12-31, per its 10-K filed 2026-02-03.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization › Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-02-03
- 2025-12-31: Property, Plant and Equipment, Gross $8.81B.
- 2024-12-31: Property, Plant and Equipment, Gross $8.99B.
- 2023-12-31: Property, Plant and Equipment, Gross $11.39B.
- 2022-12-31: Property, Plant and Equipment, Gross $11.26B.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2025-12-31 | $8.81B 10-K · filed 2026-02-03 |
| 2024-12-31 | $8.99B 10-K · filed 2026-02-03 |
| 2023-12-31 | $11.39B 10-K · filed 2025-02-05 |
| 2022-12-31 | $11.26B 10-K · filed 2024-02-12 |
| 2021-12-31 | $11.22B 10-K · filed 2023-02-10 |
| 2020-12-31 | $11.39B 10-K · filed 2022-02-09 |
| 2019-12-31 | $11.35B 10-K · filed 2021-02-10 |
| 2019-09-30 | $11.82B 10-Q · filed 2019-11-07 |
| 2019-06-30 | $11.83B 10-Q · filed 2019-08-07 |
| 2019-03-31 | $11.83B 10-Q · filed 2019-05-02 |
| 2018-12-31 | $11.80B 10-K · filed 2020-02-21 |
| 2018-09-30 | $11.98B 10-Q · filed 2018-11-01 |
| 2018-06-30 | $11.96B 10-Q · filed 2018-08-02 |
| 2018-03-31 | $12.09B 10-Q · filed 2018-05-03 |
| 2017-12-31 | $12.18B 10-K · filed 2019-02-19 |
| 2017-09-30 | $12.38B 6-K · filed 2017-11-02 |
| 2017-06-30 | $12.25B 6-K · filed 2017-08-03 |
| 2017-03-31 | $12.14B 6-K · filed 2017-05-11 |
| 2016-12-31 | $11.93B 10-K · filed 2018-02-12 |
| 2016-09-30 | $12.24B 6-K · filed 2016-11-15 |
| 2015-12-31 | $10.07B 20-F · filed 2017-02-15 |
| 2014-12-31 | $9.88B 20-F · filed 2016-02-11 |
| 2013-12-31 | $9.74B 20-F · filed 2015-02-09 |
| 2012-12-31 | $9.14B 20-F · filed 2014-02-10 |
| 2011-12-31 | $8.38B 20-F · filed 2013-02-12 |
| 2010-12-31 | $6.62B 20-F · filed 2012-02-17 |
| 2009-12-31 | $5.69B 20-F · filed 2011-02-15 |